US 12365711
TGFβ signal convertor
granted A61KA61K38/00A61K38/1793
Quick answer
US patent 12365711 (TGFβ signal convertor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/00, A61K38/1793, A61K40/11, A61K40/22